HuagongsheHuagongshe Chemistry Print Report · For research reference only
HRID 1058114Generated: October 25, 2026
Eperezolid → (S)-N-[[3-[3-Fluoro-4-[4-(hydroxyacetyl)-1-piperazinyl]phenyl]-2-oxo-5-oxazolidinyl]-methyl]acetamide N-oxide
https://huagongshe.com/reaction/1058114
Participants
| Role | Name | HCID | Charge |
|---|
| Reactant | Eperezolid | HCID 73214 | — |
| Reactant | 3-Hydroperoxyphthalic acid | HCID 19809706 | — |
| Solvent | Methanol | HCID 887 | — |
| Product | (S)-N-[[3-[3-Fluoro-4-[4-(hydroxyacetyl)-1-piperazinyl]phenyl]-2-oxo-5-oxazolidinyl]-methyl]acetamide N-oxide | HCID 86584035 | — |
Reaction Steps
(S)-N-[[3-[3-Fluoro-4-[4-(hydroxyacetyl)-1-piperazinyl]-phenyl]-2-oxo-5-oxazolidinyl]methyl]-acetamide (VIII-A, R1=COCH3, R2=H, X1=F, X2=H) (11.8 g) is dissolved in 200 mL of methanol. Monoperoxyphthalic acid, magnesium salt hexahydrate (80% pure, 18.5 g) is added and the resulting suspension is stirred at 25° C. for two hours. The reaction is filtered and the filtrate is concentrated to afford a white solid. This solid is chromatographed on silica gel using 20% methanol in chloroform as eluent to afford the N-oxide. Lyophilization of this material affords the purified product as a hydrate (9.5 g).
Provenance & Evidence
| DOI | 10.6084/m9.figshare.5104873.v1 |
|---|
| Patent number | US06515135B2 |
|---|
| Source dataset | uspto-grants-2003_02 |
|---|
| ORD ID | ord-6a6ae4790dfa44249ef186a874c2e18d |
|---|
| Source note | uspto-grants-2003_02 |
|---|